Endometrial cancer represents worldwide the sixth most common malignant pathology in the female population, the endometroid type constitutes the most common form, usually developed from a typical sequence of endometrial hyperplasia secondary to sustained exposure to unopposed estrogens balanced by progestogens. Different classification systems for endometrial hyperplasia have been described, the most recent, published by the World Health Organization in 2014, proposes two categories: 1) hyperplasia without atypia, and 2) atypical hyperplasia or endometrial intraepithelial neoplasia. This classification avoids confusion due to the different terms in use and reflects a better understanding of the pathology behavior. Atypical hyperplasia or endometrial intraepithelial neoplasia is considered a precursor lesion to endometrial carcinoma type I. Health professionals must handle standardized terminology, accurately diagnose this entity, and ensure proper treatment of it. Keywords: Endometrial intraepithelial neoplasia, Endometrial hyperplasia, Atypical hyperplasia, Endometrial cancer.
Objective: To determine the influence of the treatment received, in the quality of life and sexual function of women survivors of endometrial cancer during the period: January 2017 - August 2019. Methods: Prospective, observational, analytical, longitudinal research, in endometrial cancer survivors, to whom the SF-12 health questionnaire and the Female Sexual Function Index were applied, to determine the quality of life and sexual health respectively, before and after treatment. Results: Patients exposed to surgery alone who perceived deterioration in their physical health after treatment was 56.5 %, while in those exposed to surgery plus adjuvant treatment was 97.4 %, in those exposed to neoadjuvant treatment plus surgery was 100.0 % as in those exposed to external radiotherapy only. No patient treated with surgery or external radiotherapy alone perceived deterioration in their mental health after treatment, while the patients undergoing surgery plus adjuvant treatment the percentage was 33.33 % and in those exposed to neoadjuvant treatment plus surgery was 12.50 %. 40 women had sexual dysfunction after treatment, 65.5 % of women undergoing surgery alone, 93.3 % of those undergoing surgery plus adjuvant treatment and 100 % of those exposed to neoadjuvant treatment plus surgery. Conclusion: The prevalence of deterioration of physical health, mental health and sexual dysfunction in women exposed to combined treatments was higher than in those exposed to surgery alone. Key words: Endometrial Cancer, Quality of Life, Sexual Function, Physical Health, Mental Health.
Objective: To estimate the incidence of cervical cancer (CCU) in the year 2020 in the gynecology oncology consultation of the Obstetrics and Gynecology Service of the Hospital “Dr. Domingo Luciani”. Method: Retrospective, descriptive study, where the clinical histories of the patients diagnosed with cervical cancer who attended the first oncology gynecology consultation were reviewed, the period from January to December 2020. Results: Sixty patients met the inclusion criteria, the variables studied were age, histological type, stage at the time of diagnosis and indicated treatment;14.52% were diagnosed with cervical cancer; the mean age at the time of diagnosis was 43.15 years; the most common histological group was squamous, (96.67%). Regarding staging, 28 cases (46.67%) were diagnosed in stage IIIB, 14 cases (23.33%) in stage IIB, and only 6.66% were diagnosed in early stages. Treatment indicated radiotherapy and chemotherapy. Conclusion: We show in the present study that cervical cancer represents a significant percentage of gynecological consultations, that unfortunately the diagnosis is made in advanced stages, negatively affecting the prognosis of these patients and that the age at which it predominates is in full productive life of the women. affected women, constituting a real public health problem and chaos for families and society. Keywords: Cervical cancer, Incidence, Carcinoma, Adenocarcinoma, Stage
Los tumores de Células de la Granulosa (TCG), son neoplasias poco frecuentes, pertenecientes a los tumores del estroma y cordones sexuales del ovario, comúnmente diagnosticados en estadios iniciales y con tendencia a la recurrencia posterior a los 5 años. Se describe un caso de paciente con diagnóstico de tumor de células de la granulosa, tratado en 1996, quien consulta 21 años después por presentar aumento de volumen de circunferencia abdominal. Posterior a realizar estudios, se plantea diagnóstico de tumor abdominopélvico, probable recurrencia por tumor de células de la granulosa. Se realizó exéresis de la lesión tumoral por laparotomía exploradora, cuyo resultado de anatomía patológica reportó: tumor de células de la granulosa del adulto. Posteriormente, se decidió mantener en seguimiento por consulta de ginecología oncológica. La tendencia a la recurrencia tardía, y constituye un sello distintivo de este tipo de tumores que resalta la necesidad de un seguimiento prolongado.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.